168 related articles for article (PubMed ID: 7579380)
1. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32).
Louie DC; Offit K; Jaslow R; Parsa NZ; Murty VV; Schluger A; Chaganti RS
Blood; 1995 Oct; 86(8):2892-9. PubMed ID: 7579380
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.
Hernandez L; Fest T; Cazorla M; Teruya-Feldstein J; Bosch F; Peinado MA; Piris MA; Montserrat E; Cardesa A; Jaffe ES; Campo E; Raffeld M
Blood; 1996 Apr; 87(8):3351-9. PubMed ID: 8605352
[TBL] [Abstract][Full Text] [Related]
3. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
Pinyol M; Hernandez L; Cazorla M; Balbín M; Jares P; Fernandez PL; Montserrat E; Cardesa A; Lopez-Otín C; Campo E
Blood; 1997 Jan; 89(1):272-80. PubMed ID: 8978301
[TBL] [Abstract][Full Text] [Related]
4. Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma.
Fiel-Gan MD; Almeida LM; Rose DC; Takano A; Rezuke WN; Coleman WB; Garcia NF; Tsongalis GJ
Int J Mol Med; 1999 Apr; 3(4):373-9. PubMed ID: 10085408
[TBL] [Abstract][Full Text] [Related]
5. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
[TBL] [Abstract][Full Text] [Related]
6. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome.
Zoldan MC; Inghirami G; Masuda Y; Vandekerckhove F; Raphael B; Amorosi E; Hymes K; Frizzera G
Br J Haematol; 1996 May; 93(2):475-86. PubMed ID: 8639452
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas.
Aguilera NS; Bijwaard KE; Duncan B; Krafft AE; Chu WS; Abbondanzo SL; Lichy JH; Taubenberger JK
Am J Pathol; 1998 Dec; 153(6):1969-76. PubMed ID: 9846986
[TBL] [Abstract][Full Text] [Related]
8. Bcl-1/cyclin D1 in malignant lymphoma.
de Boer CJ; van Krieken JH; Schuuring E; Kluin PM
Ann Oncol; 1997; 8 Suppl 2():109-17. PubMed ID: 9209653
[TBL] [Abstract][Full Text] [Related]
9. BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
De Angeli C; Gandini D; Cuneo A; Moretti S; Bigoni R; Roberti MG; Bardi A; Castoldi GL; del Senno L
Haematologica; 2000 Sep; 85(9):913-21. PubMed ID: 10980628
[TBL] [Abstract][Full Text] [Related]
10. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma.
Koduru PR; Raju K; Vadmal V; Menezes G; Shah S; Susin M; Kolitz J; Broome JD
Blood; 1997 Nov; 90(10):4078-91. PubMed ID: 9354678
[TBL] [Abstract][Full Text] [Related]
11. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas.
Maestro R; Gloghini A; Doglioni C; Gasparotto D; Vukosavljevic T; De Re V; Laurino L; Carbone A; Boiocchi M
Blood; 1995 Jun; 85(11):3239-46. PubMed ID: 7756655
[TBL] [Abstract][Full Text] [Related]
12. Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.
Kodet R; Mrhalová M; Krsková L; Soukup J; Campr V; Neskudla T; Szépe P; Plank L
Virchows Arch; 2003 Jun; 442(6):538-47. PubMed ID: 12728315
[TBL] [Abstract][Full Text] [Related]
13. Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas.
Siebert R; Matthiesen P; Harder S; Zhang Y; Borowski A; Zühlke-Jenisch R; Plendl H; Metzke S; Joos S; Zucca E; Weber-Matthiesen K; Roggero E; Grote W; Schlegelberger B
Ann Oncol; 1998 May; 9(5):519-26. PubMed ID: 9653493
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis.
Greiner TC; Moynihan MJ; Chan WC; Lytle DM; Pedersen A; Anderson JR; Weisenburger DD
Blood; 1996 May; 87(10):4302-10. PubMed ID: 8639789
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
16. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E
Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558
[TBL] [Abstract][Full Text] [Related]
18. BCL6 rearrangement in a patient with mantle cell lymphoma.
Miura I; Ohshima A; Chubachi A; Nimura T; Komatsuda A; Utsumi S; Saito M; Machii T; Nakamura S; Seto M; Miura AB
Ann Hematol; 1997 May; 74(5):247-50. PubMed ID: 9200999
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma.
de Boer CJ; Schuuring E; Dreef E; Peters G; Bartek J; Kluin PM; van Krieken JH
Blood; 1995 Oct; 86(7):2715-23. PubMed ID: 7670110
[TBL] [Abstract][Full Text] [Related]
20. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas.
Rimokh R; Berger F; Delsol G; Digonnet I; Rouault JP; Tigaud JD; Gadoux M; Coiffier B; Bryon PA; Magaud JP
Blood; 1994 Apr; 83(7):1871-5. PubMed ID: 8142653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
